Side effects associated with pharmacotherapy for pediatric irritable bowel syndrome and functional abdominal pain -

Robyn Rexwinkel1, Judith Zeevenhooven1, Faridi S van Etten-Jamaludin2

  • 1a Pediatric Gastroenterology , Emma Children's Hospital, Amsterdam UMC, University of Amsterdam , Amsterdam , The Netherlands.

Insights

Pharmacotherapy for pediatric irritable bowel syndrome (IBS) and functional abdominal pain (FAP-NOS) has limited reported side effects, primarily mild and transient gastrointestinal and central nervous system issues. More high-quality research is needed to confirm safety in children.

Area of Science:

  • Pediatric Gastroenterology
  • Clinical Pharmacology
  • Evidence-Based Medicine

Background:

  • Irritable bowel syndrome (IBS) and functional abdominal pain - not otherwise specified (FAP-NOS) are common in children.
  • Pharmacotherapy is used to manage symptoms, but safety data in pediatric populations are limited.

Purpose of the Study:

  • To systematically review the literature on the side effects of pharmacotherapy in children diagnosed with IBS or FAP-NOS.
  • To assess the safety profile and types of adverse events associated with medications used in pediatric functional abdominal pain disorders.

Main Methods:

  • Systematic literature search of Cochrane Library, PubMed, and Embase databases (inception to May 2018).
  • Inclusion of randomized controlled trials (RCTs), cohort studies, and case-control studies in children aged 4-18 years.
  • Quality assessment of included studies and analysis of reported pharmacotherapy side effects.

Main Results:

  • Out of 4619 identified articles, 17 studies met the inclusion criteria.
  • Pharmacotherapy side effects were reported in 10/17 (59%) studies, including antispasmodics, antidepressants, antihistamines, serotonergic agents, and antibiotics.
  • The majority of side effects were mild, transient, and affected the gastrointestinal tract and central nervous system; no serious adverse events were reported.

Conclusions:

  • Data on the safety of pharmacotherapy for pediatric IBS and FAP-NOS are scarce.
  • Current evidence suggests that side effects are generally mild and transient, but high-quality research is lacking.
  • Further large, well-designed follow-up studies are necessary to establish a comprehensive safety profile.
Abstract

Related Concept Videos

Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
1.0K
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
779
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
758
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
533
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.1K
Review and Preview01:10

Review and Preview

In statistics, several tools are used to interpret the data. Measures of central tendency represent the characteristics of the data, such as mean, median, and mode. Additionally, measures of variance like standard deviation and range are used to find the spread of data from the mean. Relative standing measures the distance between data locations. Commonly used measures of relative standings are percentile, z score, and quartiles.
Percentiles are a type of fractile that partition data into...
8.4K